Lung Cancer

How a cancer diagnosis leaves one woman feeling humbled.

Disparities in lung cancer care must be closed to improve patient outcomes.

The keynote speaker at the CURE® Patient-Focused Sessions at the Annual New York Lung Cancers Symposium® heeded warning signs and urges others to do the same.

Researchers combine therapies in clinical trials to find the best match for patients with small cell lung cancer.

An aptly named app brings community to patients and caregivers around the world.

From the latest report on the “State of Lung Cancer” to NASA-style workouts for patients with cancer, here’s what is making headlines in the cancer space this week.

Researchers have discovered that a diet rich in fiber and yogurt may protect against lung cancer.

For Lung Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

From a palliative care bill clearing the House to a Washington Redskins player revealing a cancer diagnosis, here’s what is making headlines in the cancer space this week.

After a 10-year battle with cancer, the beloved actress, wife, mother and advocate passed away at 80.

Traveling helped me remove myself from the storyline of cancer and reconnect with the world around me.

Here’s a sneak peek at what’s inside our Summer 2019 issue.

The American Lung Association’s chief medical officer discusses e-cigarette use and answers common questions surrounding this increasing epidemic.

The earlier lung cancer is detected, the better chance a person has of surviving the disease. Knowing the risk factors and statistics will help you to understand how you can minimize your possibility of developing the disease.

Sometimes in life, we are fortunate enough to meet an individual who inspires us, motivating us to be our best. I was fortunate to meet Valerie “Val” Betancourt, M.S.N., RN, NP-C, OCN, over 20 years ago. Little did I know this was going to be the beginning of a wonderful friendship.

From landmark Senate legislation to the Pink Lemonade Stand Challenge, here’s what is making headlines in the cancer space this week.

GO2 Foundation will recognize Prof. Peters at the 20th International Lung Cancer Congress for her leadership in lung cancer research.

GO2 Foundation will recognize Prof. Peters at the 20th International Lung Cancer Congress for her leadership in lung cancer research.

Given with each dose of chemotherapy, trilaciclib temporarily puts bone marrow to sleep, helping to prevent fevers, infections and hospital stays in patients with small cell lung cancer.

Nominee for CURE®’s 2019 Extraordinary Healer® award, oncology nurse Megan Roy’s insight is valued and trusted by both patients and her team, making care processes smooth no matter whether she worked directly with patients or not.

From today’s top performers and athletes to surprising findings about prostate cancer treatment, here’s what is making headlines in the cancer space this week.

One expert weighs the benefits and drawbacks of expanding clinical trials to be more inclusive and reflective of the general patient population with cancer.

Studies show that the social stigma can actually affect a patient’s level of care and lead to worse health outcomes.

Tumor mutation burden may be an independent predictor of developing depression in patients with lung cancer, according to Dr. Daniel McFarland.

The growing use of telecommunication and technology to provide health care – or telemedicine – offers many advantages, but also comes with challenges, says one expert.

Trilaciclib, an intravenous CDK 4/6 inhibitor, in combination with Hycamtin may reduce chemotherapy-induced myelosuppression in small cell lung cancer, according to one expert.

From cancer-sniffing dogs to music therapy for pain, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration approved Keytruda for the treatment of patients with metastatic small cell lung cancer.

Autoimmune skin toxicities in patients with non-small cell lung cancer mean patients may respond better to immune checkpoint inhibitors.